BioCentury
ARTICLE | Company News

Antegrin, Cascadia deal

October 24, 2016 7:00 AM UTC

Antegrin and Cascadia merged to form Indalo Therapeutics Inc. (St. Louis, Mo.). The newco is developing treatments for fibrotic diseases affecting the kidney, liver, and lung using Antegrin’s portfoli...